Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
US Department of Justice
Citi
UBS
AstraZeneca
Teva
Accenture
Cantor Fitzgerald
Dow

Generated: April 23, 2018

DrugPatentWatch Database Preview

JEANATOPE Drug Profile

« Back to Dashboard

Which patents cover Jeanatope, and what generic alternatives are available?

Jeanatope is a drug marketed by Iso Tex and is included in one NDA.

The generic ingredient in JEANATOPE is albumin iodinated i-125 serum. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the albumin iodinated i-125 serum profile page.
Summary for JEANATOPE
Drug patent expirations by year for JEANATOPE
Pharmacology for JEANATOPE

US Patents and Regulatory Information for JEANATOPE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Iso Tex JEANATOPE albumin iodinated i-125 serum INJECTABLE;INJECTION 017836-003 Jun 8, 2004 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Iso Tex JEANATOPE albumin iodinated i-125 serum INJECTABLE;INJECTION 017836-001 Approved Prior to Jan 1, 1982 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Iso Tex JEANATOPE albumin iodinated i-125 serum INJECTABLE;INJECTION 017836-002 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Farmers Insurance
Cipla
Merck
Argus Health
Chubb
Colorcon
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.